Skip to main content

Researchers Identify Two Main Motivating Factors Behind Unregulated Cannabis Purchases

Legal cannabis is spreading across the planet, and with it, purchasing freedoms for some consumers. Yet, the unregulated market still exists even where cannabis can be purchased legally. Researchers at the University of Waterloo in Ontario recently examined the factors that motivate a consumer or patient to purchase unregulated cannabis versus regulated cannabis in North America in an attempt to understand why the unregulated market still exists in Canada despite legalization, and to a lesser extent, the United States.

By human history standards, cannabis prohibition is a relatively new thing. After all, cannabis is not a new plant and humans have used it for medical and recreational purposes for centuries. It wasn’t until the last century that political forces prohibited it. Fortunately, three countries have now legalized cannabis for adult use – Uruguay, Canada, and Malta. Cannabis can be legally acquired in some form in Uruguay and Canada, and soon, Malta.

Out of the three countries, Canada has the most robust industry model. Cannabis consumers of legal age from anywhere around the planet can come to Canada and make a legal purchase through a storefront dispensary, through the mail, and/or through delivery services. Similar options have existed in the U.S. at the state level for many years. Researchers have kept a close eye on North America as the ‘cannabis experiment’ has continued to roll out, including researchers at the University of Waterloo in Ontario.

Motivating Factors

The average cannabis consumer is more sophisticated now than arguably any other time in human history, and that is largely due to the options available to them, particularly in Canada. Some consumers want to smoke cannabis flower, some want to vaporize it, and still, many others prefer smokeless forms of cannabis such as edibles and topicals.

Regulated industries boost the options for patients and consumers. I live in a legal jurisdiction, and the different types of cannabis products and consumption methods are exponentially greater now compared to when there was no regulated market With that being said, the unregulated market still exists where I live, albeit at a much lower level than before legalization.

Researchers at the University of Waterloo in Ontario looked at consumer data from 2019 and 2020. The data was compiled as part of the annual International Cannabis Policy Study. Survey data asked consumers about their purchasing habits over the past 12 months, and when they indicated that they purchased cannabis from an unregulated source they were provided a list of reasons to select from regarding what motivated the unregulated purchase.

“‘Legal sources had higher prices’ was the number-one answer in Canada in both years (35.9% in 2019, 34.6% in 2020) as well as in the United States (27.3% in 2019, 26.7% in 2020). Convenience (both ‘legal sources were less convenient’ and ‘legal stores were too far away/there are none where I live’) was high on the list as well, with the percentage of respondents who named these as reasons ranging from 10.6% to 19.8%.” researchers stated in their press release.

Sensible Regulations To Help Boost Legal Sales

On average, the cost of legal cannabis will always be greater than unregulated cannabis. A legal cannabis company has to pay ongoing licensing and compliance fees, rent on their commercial facilities, and a number of other operational costs that do not exist in the unregulated market. All of those added layers contribute to the overall cost of legal cannabis.

Speaking anecdotally, I am willing to pay extra for legal cannabis being that it is tested and regulated. However, there is a point to how much more I am willing to pay, and I assume many consumers are the same as me in that regard. Paying 10% more is reasonable, however, if legal cannabis costs 2-4 times as much as unregulated cannabis, clearly many people will choose to go the unregulated route.

The second motivating factor identified by the researchers, convenience, is much easier to address from a public policy standpoint. Boosting the ways in which consumers and patients can legally acquire cannabis helps a considerable amount. Conversely, the fewer ways people can legally acquire cannabis the more it creates opportunities for unregulated sources to fill the void and meet the demand. Jurisdictions that choose to cling to prohibition or hinder safe access do so at their own peril.

Lawmakers around the world need to do everything that they can to strike the right balance between regulating cannabis, generating public revenue, and implementing sensible regulations that help keep the cost of legal cannabis down as much as reasonably possible. Everyone needs to temper their expectations when it comes to getting rid of the unregulated market. Just as there will always be a market for unregulated alcohol, so too will there always be an unregulated market for cannabis, at least to some degree.

Jamaica Medical Cannabis Development Task Force Report Is Complete

Historically, Jamaica is one of the top countries associated with cannabis on the planet, and a very strong argument could be made that it is the country most associated with cannabis.

The Caribbean island nation is home to a large population of people that use cannabis for sacramental purposes, and it is no secret that the cannabis plant grows naturally all over Jamaica and that it is sought after by people all over the world.

As the emerging cannabis industry continues to spread across the globe and increase in size at an exponential rate it is no surprise that Jamaica is trying to take its rightful place as an international cannabis powerhouse.

Jamaica inched closer to that goal when it was announced earlier this month that the country’s cannabis task force has completed a report that it will present to lawmakers in the near future. Per Jamaica Observer:

The cannabis development task force, set up by the Government, has completed a comprehensive action plan with key initiatives to support the medical marijuana industry, to include small and traditional ganja farmers.

State minister for industry, investment and commerce, Dr Norman Dunn, stressed in his contribution to the 2022/23 Sectoral Debate in the House of Representatives Tuesday that “the industry is demanding that we aggressively implement the action plan in the 2022/23 financial year, and we are responding decisively”.

Small farmers have complained over the years that although laws were passed to decriminalise possession of a small quantity of marijuana and make way for the growth of a medical marijuana industry, the requirements of the legal framework places them at a severe disadvantage.

It’s not clear at this time exactly what is included in the report, however, as the previously cited media coverage touched on, it’s expected to have a focus on helping small farmers.

Meanwhile, the Westmoreland Hemp and Ganja Farmers Association is promoting its own proposal to help small farmers and entrepreneurs via a cannabis ‘free zone.’

Essentially, the zone would somewhat mimic that of Amsterdam to some degree, where cannabis commerce could be freely conducted within the zone similar to how coffee shops have historically operated in Amsterdam. Only time will tell if the proposal gets adopted.

Italian Ministry Of Défense Publishes Pre-Bid Call For New Cannabis Cultivation Companies

The Ministry is trying to identify qualified cultivators to cultivate in Florence

The Ministry of Defense has just published an “expression of interest” to identify companies that are able and qualified to grow medical cannabis plants. The call was designed to increase production for domestic use with the aim of achieving self-sufficiency from a medical perspective.

A technical department has been set up to begin this definitive start to call for new tenders for medical cultivation. The direct link can be found here.

Qualifications are broken into four sections – with the first qualification being GMP certification.

  • Qualitative selection of candidates
  • Technical inspection
  • Confirmation of expression of interest
  • Invitations to apply (which is restricted)

Both existing farms and freelancers registered with the Chamber of Commerce, or the competent professional associations will be considered, providing that they have the right experience as well as an in-depth understanding of the current legislation. A valid insurance policy of at least 10 million euros will also be required.

The due date is June 27.

The Domestic Security Argument

The Italian decision to increase the domestic production of cannabis (by highly limited tender bid) certainly comes at an interesting time, particularly given pending recreational reform just across the border with Germany. While ostensibly just for domestic consumption, it is unclear if Italy wants to also position itself as a major exporter as other markets come online – particularly those like Luxembourg where for now, the only cannabis cultivation that is going to be allowed in the short term is home grow.

Beyond this, the moves seem to be the first in Europe where authorities consider cannabis so valuable that they are specifically setting up cultivation to meet so far unmet domestic supply – and further as a self-identity national security issue.

Just across the border in Germany, the three cultivators who won the first bid were deliberately instructed to grow far less than would be obviously needed. This is why the ex-im market aus Deutschland is so dynamic, not to mention important.

That said, this may mark a turning point for the discussion, not just in Italy, but across Europe. Supply chain security for both food and medicine has become a much hotter topic post Pandemic, with convoluted supply chains and a re-examination of national policies in shoring up as much domestic production as possible.

It is also, of course, a tacit admission of the huge job creation potential of the sector.

The Italians, in other words, are not just releasing a domestic agricultural tender. They might well be on the edge of a coming, new, and much overdue green flood that seems poised to take over Europe.

Brazilian Medical Cannabis Consumption Increases 110% In One Year

Consumption of medical cannabis products in Brazil increased by 110% in 2021 from 2020 according to study by BRCANN, the Brazilian Association of the Cannabinoid Industry

Brazil is moving rapidly into the global cannabis arena. Currently, the country imports 18 cannabinoid drugs. Beyond this, last year, 40,191 people filed permits to individually import cannabinoids for personal, medical use. The year before, only 19,150 applications were filed. And between 2015 and 2021, a total of 75,203 applications were granted.

Brazil is not so quietly now grappling with where to go with cannabis reform, even as medical use soars in the country.

The current president, Jair Bolsonaro, is vigorously and vocally against any kind of cannabis reform. However, he is being challenged on this stance, both by the populace itself and now by candidates challenging him in this year’s presidential race.

Given the changing climate, whoever wins will almost certainly be dealing with the issue of domestic cultivation and processing. Currently, there are only a few projects authorized to cultivate medical cannabis, and most of this is for research purposes.

This will probably start to change, particularly as it is much cheaper to cultivate cannabis domestically than to import it. Especially in a country like Brazil.

Questions About Sustainability

Brazil has a climate well suited to the cultivation of cannabis. However, there are a few looming problems in the entire legalization discussion.

The first is sustainability. Brazil is already facing record levels of deforestation. The outdoor cultivation of cannabis would, in all reality, increase the pace of the same unless effective regulation of the industry takes place. How likely that is in the current environment is debateable.

One of the primary causes of deforestation is the use of fragile rainforest land to cultivate illicit crops including drugs.

It is also highly unlikely that cultivation would occur only for domestic use.

A Latin American Revolution

Brazil may be one of the larger Latin American countries to consider cannabis reform, but it is far from the only one. That is what makes reform here inevitable, beyond the use of the drug for medical purposes by citizens.

That is also why the industry must be carefully planned and thought out.

An effective domestic program would have to create jobs and incentivize people not to grow crops on fragile land.

For this very reason, reform in this part of the world may have a much wider impact on the rest of the industry, which is struggling everywhere, with both costs and sustainability issues, starting with the cost of electricity.

But make no mistake about it. Reform is coming to Latin America and Brazil is just moving with the herd.

Honduras Vice President Wants To Create 85,000 Cannabis Jobs

One of the biggest selling points for reforming cannabis laws, for better or worse, is the industry component. Studies and polls have consistently found that more people support legalizing a taxed and regulated industry than just simply removing prohibition for personal use.

An example of this can be found in the results of a recent poll conducted in Australia. When asked if cannabis should be legal 50% of poll respondents expressed support for such a public policy shift. However, more people (55%) supported regulating the cannabis industry like tobacco and alcohol.

In a perfect world, people would support cannabis reform because it’s the right thing to do. In a less perfect world, some amount of voters need a societal financial incentive in order to support cannabis reform.

Job Creation

Recent history has clearly demonstrated that when the legal cannabis industry is allowed to operate, the industry can create a significant number of jobs.

For instance, the legal cannabis industry is responsible for creating over 151,000 jobs in Canada, and at least another 428,000 in the United States. You can compare those numbers to the number of jobs in other large industries and you will quickly see the job creation potential of the emerging cannabis industry.

Consider the fact that the United States Bureau of Labor and Statistics estimates that there are 285,980 hairdressers, hairstylists, and cosmetologists in the U.S.

The legal cannabis industry clearly exceeds that number. The cannabis industry’s job creation potential is even more impressive when considering that cannabis is still prohibited at the federal level in the United States.

Once the legal cannabis industry is permitted to exist in as many places as salons, the number of jobs in the legal cannabis industry will be exponentially greater than it is currently.

Honduras

The Vice President of Honduras has expressed a very strong desire to legalize medical cannabis in his country, seeming to be largely motivated by the industry’s ability to create jobs.

“First, what I propose is a project to generate employment and to generate foreign exchange for the country. I’m not thinking of legalizing marijuana, nor the medicinal part. There are simply two objectives: to generate employment, because -for example- 5,000 hectares generate 85,000 jobs and we have a deficit of half a million unemployed. Apart from that, it is a millionaire business, because the countries that are close to the equator have sun all year round, we have excellent lighting. So, the cost of production is low, it is so low that producing a gram costs 15 cents of a dollar and producing the same gram in Europe or the United States costs above 1 dollar.” Honduras’ Vice President Salvador Nasralla stated in a recent interview with El Planteo.

Honduras has a population of roughly 10 million people, with roughly 6.4 million of them being 18 years old or older. The unemployment rate among Honduras’ labor force is about 10%, so the creation of 85,000 jobs would provide a tremendous boost to the struggling country.

Cannabis reform is not imminent in Honduras, however, the country is definitely trending in the right direction. It will be a while before the country generates the number of jobs that Vice President Nasralla is hoping for, but any number of legal cannabis jobs is better than the current situation.

CBD Hemp Business Fair Is Coming To Spain

Cannabidiol (CBD) currently has the designation of being the most popular cannabinoid on earth. As proof of that claim, consider the fact that CBD is searched more often on Google than any other cannabinoid, including tetrahydrocannabinol (THC), and that’s been the case since December 2016.

In addition to being queried more often on the world’s most popular online search engine than its cannabinoid counterparts, hemp-derived CBD is legal in far more regions of the planet compared to THC. It is estimated that the global CBD market was worth nearly 5 billion USD in 2021 and that it could be worth as much as 47 billion USD by 2028. That figure doesn’t include the global market for industrial hemp, which is set to experience a 33%+ compounded annual growth rate through 2030 according to at least one estimate.

You will be hardpressed to find an industry that is already worth billions of dollars and yet is still set to experience the level of exponential growth that the global CBD and industrial hemp industry will experience in the coming years. There is literally no better time to get into the CBD industry than right now, and a great way to do exactly that is to attend the upcoming CBD Hemp Business Fair in Barcelona on October 7-9, 2022.

Spannabis, the world’s largest cannabis trade show with more than 20 years of experience, is launching this amazing new event focused on CBD and industrial hemp. The fair is expected to have more than 100 brands present on a 12,000 square meter expo floor. Over 1,500 industry professionals and 15,000 visitors are expected to be in attendance over the course of the 3-day event.

CBD Hemp Business Fair will feature an event networking app that helps facilitate collaborations between exhibitors and event attendees before and during the event. The app is a very useful tool to promote companies, make appointments, and discover new potential clients.

The event’s showroom will feature demonstrations, presentations, and entertainment including cooking demonstrations and live music. The event will also include an outdoor food truck area, the CBD Champions Cup, and the CBD and Hemp Awards. If you want to get into the emerging CBD and hemp industry, or just want to learn more about its products and services, you do not want to miss this event!

Israeli Medical Cannabis Seeds Legally Shipped To U.S. In Historic First

In a historic first, medical cannabis seeds were legally exported this week from Israel to the United States according to Israel’s Agriculture Ministry. Last August Israel’s government reformed cannabis export laws to permit the legal export of medical cannabis seeds, with this week’s shipment to the United States serving as the culmination of many months of effort.

For many decades Israel has served as an international leader when it comes to medical cannabis research. After all, Israel is the home of famed chemist Raphael Mechoulam who is credited with being the first to isolate both CBD and THC back in 1963 and 1964 respectively. From the 1960s until fairly recently, Israel was one of the very few countries that even permitted large-scale cannabis research, let alone embraced it.

Heavily-Researched Cannabis Genetics

It’s not a leap to assume that Israel is sitting on some amazing cannabis genetics given the amount of research its scientists have conducted over so many years. What type of strain(s) were involved in Israel’s first legal cannabis seed exportation is unclear. Who will be on the receiving end of the shipment is also unclear. All that was referenced in the Israeli government’s announcement on that front was, “Upon arrival, the seeds will be examined by commercial hemp growers to verify their suitability for the US market.”

The specific seeds at the heart of this story sent from Israel to the United States originated from the BetterSeeds company. Per the BetterSeeds company’s website, “BetterSeeds makes use of genome editing technology (CRISPR-Cas9) in order to produce new varieties, incorporating game changing traits which are not today available across all crops due to the limitations of conventional breeding. Genome editing technologies make precise and rapid breeding possible by introducing specific, controlled and preselected changes in the plant genome.”

BetterSeeds produces more than just cannabis seeds and appears to produce seeds for nearly every type of major crop imaginable. I know that when I read ‘genome editing technologies’ it gave me a bit of heartburn, and I know that I am likely not alone in feeling that way.  However, the seeds that were sent to the United States are proprietary in nature, so we may never know for sure what they are and/or how they may have been altered in some manner.

A Small, Significant Milestone

This first-ever legal shipment of cannabis seeds from Israel out to the international community is worth keeping in context. It is essentially a test run to help ensure that the shipment can be performed and completed in a way that complies with regulations in both Israel and the United States, as well as within evolving international cannabis policy (at least to some degree).

“The shipment is an experimental and initial shipment, after which contacts will be made regarding the continued export. This is a historic step as part of the implementation of Government Resolution No. 4490, which was updated last August to include the export of medical cannabis seeds from Israel, and could lead to the opening of additional international markets for Israeli exports and significantly advance the medical cannabis industry in Israel.” the Ministry stated in its press release.

“The opening of seed exports in the field of cannabis is expected to strengthen Israel’s position as having knowledge and expertise in the field of seeds. In addition, increasing the range of exports and expanding it to cannabis products, will enable the deepening of existing markets and penetration into new markets while riding on the growing wave of demand for cannabis products with medical-health value. Moreover, Israel is among the leading countries in seed research and development in general as well as medical cannabis in particular, and cannabis seed exports are expected to attract interest from various researchers around the world and further strengthen the field of research.” the Ministry also stated in its press release.

Obviously, this is not the first time that cannabis seeds have been shipped from one part of the world to another. It’s quite likely, if not guaranteed, that seeds from Israel have specifically made it from Israel to the United States in the past, albeit illegally. Still, this is a big milestone for a country that is sitting on a wealth of knowledge, experience, and other valuable assets, including genetics. Hopefully it leads to a much larger global involvement for Israel within the emerging international cannabis industry.

Australia Has Issues A Quarter Million Cannabis Prescriptions Since 2016

Medical cannabis is increasingly prescribed for a multitude of conditions. Where does this indicate that the market ‘down under’ is headed?

According to researchers from the University of Sydney at the Lambert Initiative for Cannabinoid Therapeutics, anxiety, chronic pain and sleep disorders are the top three reasons that Australians seek a cannabis prescription. This is despite the limited number of trials supporting its use for either anxiety or sleep disorders.

Prescriptions have also increased dramatically over the last two years – although researchers were unable to determine if the rise in such requests was due to the Pandemic. Another unexplained trend revealed by the data set that has been gathered since the beginning of medical reform showed that Queensland prescribers represented over half of the prescriptions written nationally.

How Does This Compare with Germany?

Australia is perhaps the closest “Western” country to Germany in terms of timing and approach to initializing the legal cannabis market. Both countries approved medical use on a federal level about the same time (within a year of each other). And while Germany’s total number of prescriptions outnumbers the Australian total so far, they are certainly comparable.

The difference between the two countries, however, is that Germany is now moving solidly towards a recreational market. Australia seems mired in indecision.

When Will It Get Dank Down Under?

In Europe, there is now a pressing regional political issue to deal with. Namely, there is no way that Germany can sit the recreational reform question out with countries all around it (and in two cases bordering it) now proceeding with federally regulated recreational cannabis markets. Australia is a bit isolated in this regard, although it is, as a country, clearly following the global trend.

Australian producers are also trying to export to Germany (as well as eastern Europe).

The latest poll numbers show that Australians are currently split, 50-50 on whether the country should proceed with a recreational market. That has moved fairly dramatically in the last several years.

For this very reason, it is also highly likely that, at a bare minimum, the initiation of a recreational market in Germany might tip the scales. Everyone right now is looking for a new industry or line of revenue post Covid.

And then of course there is the ability to export to a fully recreational market or two in Europe.

Given all the possibilities now at stake, it is very likely that Australia will be one of the next major western economies to make the switch. Even if so far unannounced.

Ontario Cannabis Store Data Breach Demonstrates Growing Threat

I have worked in the cannabis industry to some degree for many years now. If you count the unregulated industry here in Oregon, I am the third generation of my family to be involved with cannabis.

If there is one thing that I know about the emerging cannabis industry it’s that cannabis and chaos seem to go hand-in-hand. Laws. Rules. Regulations. Juggling all of it while all of the parts are moving and shifting, all the while trying to be innovative and effective at running a business. There is a lot that cannabis entrepreneurs and their employees have to stay on top of and it can be like trying to drink water from a fire hydrant.

One area of the emerging cannabis industry that seems to often get lost in all of the chaos is information security, which is unfortunate. When people think of information security, they often think of computers and networks, and rightfully so. Computer networks often house a significant amount of sensitive information.

However, there is far more to information security than computers and networks. Companies and employees in the cannabis industry often house more sensitive information than people realize in both digital and physical forms, including personally identifiable information and proprietary information. All of that information is a target for someone.

Whereas network security can be easily outsourced to a reputable third party, the biggest threat to a cannabis company’s information security strategy has to be addressed on an ongoing basis in-house because that threat is the company’s own staff, either due to nefarious intent or negligence.

A cannabis company can have the most robust technical safeguards in place, with a small army of network security experts doing everything they can to keep something secure, and it only takes one person with privileged access to give up some or even all of the company’s sensitive information via less-than-sophisticated methods.

The latest example of the growing information security issue facing the emerging cannabis industry can be found in Canada where a suspected data breach is making headlines. Per Infotel:

The Ontario Cannabis Store says a data breach involving some of its sales information is being investigated by the Ontario Provincial Police.

Daffyd Roderick, a spokesperson for the Crown agency responsible for distributing cannabis from producers to pot shops in the province, confirmed what he called a misappropriation of data Tuesday evening.

“There was no failure of IT security or systems,” he added.

An OCS letter obtained by The Canadian Press and sent to retailers on May 10 said that “confidential store sales data” was being “circulated in the industry.”

“This data was not disclosed by the OCS, nor have we provided any permission or consent to distribute or use this data outside of our organization,” reads the letter signed by Janet Ihm, the OCS vice-president of wholesale partnerships and customer care.

“The data was misappropriated, disclosed, and distributed unlawfully. As a result, we trust you will refrain from sharing or using this stolen data in any way.”

As noted by authorities in the excerpt, the data breach did not come as a result of a failure of ‘IT security or systems,’ meaning, it wasn’t a direct hack into the system. Many details are still unknown, however, I would personally bet a decent chunk of change that the breach was due to non-sophisticated methods.

One of the most common ways that data breaches occur is through human error. Sometimes someone from the data source sends an email to an auto-populated wrong email address in error. Sometimes they click the wrong attachment when sending an email and the data is acquired that way, or they click ‘reply all’ when they shouldn’t have. Although, that doesn’t seem to be the case in Ontario where the ‘data was not disclosed by the OCS.’ I take that to include no direct disclosures even due to human error.

Perhaps the data was gained through some type of physical theft. When I read the word ‘misappropriated’ that is where my mind went based on the currently available information. All it would take is someone copying one or more files to a digital storage medium (disc, thumb drive, phone, etc.) containing the data in question, and simply walking off with it. Everyone has a phone in their pocket these days, and taking a picture of sensitive information is very easy to do.

Regardless of how the data was obtained in this latest case, the case itself serves as a reminder that the cannabis industry is a popular target. The industry has so much money flowing through it, it’s so competitive, and many in the industry seem to be unaware of the amount of sensitive information that they have at their fingertips. The problem will only continue to get worse.

Everyone in the cannabis industry needs to be mindful of information security threats, trends, and tactics. Companies need to train their staff, continue to educate members of their organization and create effective information security policies. One silver lining in all of this is that it creates many opportunities for ancillary companies that can help cannabis companies and organizations with their information security strategies.